Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Atara Biotherapeutics, Inc. (ATRA) had Receiveable Turnover of 0.25 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$8.57M |
|
$-276.13M |
|
$8.89M |
|
$-0.31M |
|
$284.58M |
|
$-276.01M |
|
$-0.10M |
|
$-276.11M |
|
$-276.11M |
|
$-276.13M |
|
$-276.13M |
|
$-276.13M |
|
$-276.13M |
|
$-276.01M |
|
$-270.38M |
|
105.91M |
|
105.91M |
|
$-2.61 |
|
$-2.61 |
|
| Balance Sheet Financials | |
$101.87M |
|
$3.86M |
|
$63.63M |
|
$165.50M |
|
$142.23M |
|
-- |
|
$122.51M |
|
$264.74M |
|
$-99.23M |
|
$-99.23M |
|
$-99.23M |
|
106.45M |
|
| Cash Flow Statement Financials | |
$-192.98M |
|
$123.87M |
|
$2.01M |
|
$93.09M |
|
$25.99M |
|
$-67.10M |
|
$45.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.65% |
|
-3219.48% |
|
-3219.48% |
|
-3153.91% |
|
-3220.70% |
|
-3220.88% |
|
$-194.18M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.92 |
|
|
Receiveable Turnover |
0.25 |
1452.17 |
|
278.27% |
|
278.27% |
|
-166.84% |
|
278.27% |
|
$-0.93 |
|
$-1.83 |
|
$-1.82 |
|